scholarly article | Q13442814 |
P356 | DOI | 10.1158/1078-0432.CCR-05-2814 |
P698 | PubMed publication ID | 16857800 |
P2093 | author name string | Surinder K Batra | |
Kohzoh Imai | |||
Michiyo Higashi | |||
Masamichi Goto | |||
Suguru Yonezawa | |||
Hiroaki Shibahara | |||
Shugo Tamada | |||
P2860 | cites work | The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen | Q52827123 |
P433 | issue | 14 Pt 1 | |
P921 | main subject | extrahepatic bile duct carcinoma | Q18556429 |
bile duct carcinoma | Q11611688 | ||
P304 | page(s) | 4257-4264 | |
P577 | publication date | 2006-07-01 | |
P1433 | published in | Clinical Cancer Research | Q332253 |
P1476 | title | MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma | |
P478 | volume | 12 |
Q34796803 | A comprehensive expression analysis of mucins in appendiceal carcinoma in a multicenter study: MUC3 is a novel prognostic factor |
Q34060189 | Aberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases |
Q92029274 | Assessing the prognostic significance of MUC4β in mucoepidermoid carcinoma of the salivary glands: An immunohistochemical study |
Q40694864 | Characterization of progressive metaplasia in the gastric corpus mucosa of Mongolian gerbils infected with Helicobacter pylori |
Q33879485 | Clinicopathologic significance of slug expression in human intrahepatic cholangiocarcinoma |
Q26784326 | Clinicopathological and prognostic significance of MUC4 expression in cancers: evidence from meta-analysis |
Q88039920 | Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma |
Q93184511 | Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas |
Q57300567 | Current and future roles of mucins in cholangiocarcinoma-recent evidences for a possible interplay with bile acids |
Q37187307 | Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours |
Q38662233 | Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity |
Q90260379 | Diversity of mucins in labial glands of infants |
Q36001870 | Epigenetic regulation of mucin genes in human cancers |
Q41465482 | Expression of MUC1 and MUC4 in gallbladder adenocarcinoma |
Q37188897 | Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas |
Q58122566 | Extracellular Vesicles in Hepatobiliary Malignancies |
Q35035530 | Genetic variants in MUC4 gene are associated with lung cancer risk in a Chinese population |
Q33963953 | High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma |
Q37206290 | Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma |
Q34477871 | MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer |
Q36667483 | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. |
Q79847238 | MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells |
Q37030117 | MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells. |
Q24601584 | Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells |
Q41379077 | Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer |
Q36537065 | Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery. |
Q34008828 | Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer. |
Q33674729 | Muc4/MUC4 functions and regulation in cancer |
Q36437150 | Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. |
Q24633765 | Mucins in cancer: function, prognosis and therapy |
Q28070355 | Mucins in neoplasms of pancreas, ampulla of Vater and biliary system |
Q64093534 | Mucins: the Old, the New and the Promising Factors in Hepatobiliary Carcinogenesis |
Q41922735 | Mucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus? |
Q35145588 | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer |
Q51802126 | Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies. |
Q36053164 | Prognostic Role of Mucin Antigen MUC4 for Cholangiocarcinoma: A Meta-Analysis |
Q36285659 | Prognostic significance of membrane-associated mucins 1 and 4 in gastric adenocarcinoma. |
Q36406805 | Prognostic significance of muc4 expression in gallbladder carcinoma |
Q34121441 | Prognostic significance of mucin expression in urothelial bladder cancer |
Q34023248 | Prognostic value of mucin 4 expression in colorectal adenocarcinomas |
Q39898076 | Promoter CpG methylation in cancer cells contributes to the regulation of MUC4. |
Q40220702 | Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha. |
Q48553032 | Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. |
Q34493341 | The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis |
Q36127379 | Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies |
Search more.